Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/82082
Full metadata record
DC FieldValueLanguage
dc.creatorVale Costa, S
dc.creatorCosta Gouveia, J
dc.creatorPerez, B
dc.creatorSilva, T
dc.creatorTeixeira, C
dc.creatorGomes, P
dc.creatorGomes, MS
dc.date.accessioned2022-09-09T08:21:24Z-
dc.date.available2022-09-09T08:21:24Z-
dc.date.issued2013
dc.identifier.issn0066-4804
dc.identifier.othersigarra:89186
dc.identifier.urihttps://hdl.handle.net/10216/82082-
dc.description.abstractA series of cinnamic acid conjugates of primaquine and chloroquine were evaluated for their in vitro antileishmanial activities. Although primaquine derivatives had modest activity, chloroquine conjugates exhibited potent activity against both promastigotes (50% inhibitory concentration [IC50] = 2.6 to 21.8 mu M) and intramacrophagic amastigotes (IC50 = 1.2 to 9.3 mu M) of Leishmania infantum. Both the high activity of these chloroquine analogues and their mild-to-low toxicity toward host cells make them promising leads for the discovery of new antileishmanial agents.
dc.language.isoeng
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.subjectMedicina básica
dc.subjectBasic medicine
dc.titleN-Cinnamoylated Aminoquinolines as Promising Antileishmanial Agents
dc.typeArtigo em Revista Científica Internacional
dc.contributor.uportoFaculdade de Ciências
dc.contributor.uportoInstituto de Ciências Biomédicas Abel Salazar
dc.identifier.doi10.1128/aac.00557-13
dc.identifier.authenticusP-006-6Z9
dc.subject.fosCiências médicas e da saúde::Medicina básica
dc.subject.fosMedical and Health sciences::Basic medicine
Appears in Collections:FCUP - Artigo em Revista Científica Internacional
ICBAS - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
89186.pdf203.29 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons